Select Medical Holdings Corporation reported revenue of $1,363.4 million for the third quarter ended September 30, 2025, an increase of 7.2% compared to $1,271.6 million in the same quarter of the previous year. Income from continuing operations before other income and expense rose 32.9% to $73.0 million, up from $54.9 million in the prior year period. Income from continuing operations, net of tax, increased 7.0% to $44.2 million, compared to $41.3 million for the same quarter in 2024. For the nine months ended September 30, 2025, revenue was $4,056.2 million, representing a 4.7% increase over $3,874.5 million in the prior year period. The company reaffirmed its 2025 full-year outlook for revenue in the range of $5.3 billion to $5.5 billion and Adjusted EBITDA between $510.0 million and $530.0 million. The outlook for fully diluted earnings per share was increased to a range of $1.14 to $1.24. Net income attributable to Select Medical's common stockholders for the third quarter was $55.6 million, compared to $28.8 million for the same period last year. Total earnings per common share were $0.43, up from $0.23 in the prior year quarter.